Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Temple study identifies molecular mechanisms that may assist gene in blocking lung cancer

09.10.2003


Dr Antonio Giordano, director of the Sbarro Institute for Cancer Research and Molecular Medicine based at Temple University.
Photo Credit: Joseph V. Labolito


The molecular mechanisms that may assist the tumor suppressing gene Rb2/p130 in blocking the progression of lung cancer cells has been clearly identified for the first time according to a study by researchers at Temple University’s Sbarro Institute for Cancer Research and Molecular Medicine.

The results of their study, "pRb2/p130 target genes in non-small cell lung cancer cells identified by microarray analysis," appear in the Oct. 9 issue of Oncogene (http://www.nature.com/onc/).

The study, led by Antonio Giordano, M.D., Ph.D., head of the Sbarro Institute at Temple, was a follow-up to previous experiments led by Giordano that demonstrated an inverse relationship between Rb2 expression and the aggressiveness of lung cancer. Giordano discovered the Rb2 gene while working at Temple’s Fels Cancer Institute in the early 1990s. In those earlier studies, correct copies of Rb2 were introduced into mice with lung tumors using a viral system developed by Pier Paolo Claudio, M.D., Ph.D., associate professor of biotechnology at the Sbarro Institute. When the Rb2 gene was over-expressed in the cancer cells, it caused the tumors in the mice to completely regress(http://jncicancerspectrum.oupjournals.org/jnci/content/vol90/issue19).



"In this study, we wanted to understand the molecular mechanisms behind Rb2/p130 tumor growth inhibition," says Giuseppe Russo, Ph.D., a post doctoral fellow at the Sbarro Institute and the study’s lead author. "We wanted to know what this gene does in lung cancer cells, what other genes it may target, and how it controls cell regulation.

"It’s like this molecular process of tumor regression is a movie and Rb2 is the lead actor," Giordano adds. "What we wanted to know is who the supporting cast is."

After introducing correct copies of Rb2 into H23 lung cancer cells via Claudio’s viral shuttle, the researchers used customized microarray analysis to examine the simultaneous expression of thousands of genes within the cancer cell. Microarray is a powerful new tool that allows researchers to study the molecular basis of interactions on a scale that had been impossible using conventional methods.

"Through the use of the microarray, we were able to see which genes were over-expressed or under-expressed because of the enhanced Rb2 gene expression," says Giordano. "This is the first time that we have been able to clearly identify the genes that were being regulated by the Rb2 expression in lung cancer cells."

Some of the nearly 70 regulated genes that were identified through this study were previously known to be involved in the progression of lung cancer, says Giordano, meaning that the researchers were able to confirm previously published data. "But many of the identified genes were not previously known to be involved in lung cancer or be regulated by Rb2," he adds. The Temple researchers believe that identifying these genes could play an important role in developing future gene therapies to diagnose and treat lung cancer.

"Any regulation in a gene that is found to be caused by Rb2 is important to us because we can then study why that gene is regulated and use that information to develop molecular therapeutic approaches to lung cancer," says Giordano. "The gene expression profiles provided by microarray analysis will someday help tailor specific gene therapies to individual patients." Lung cancer is the leading cause of cancer death worldwide and is usually diagnosed at an incurable stage, most likely due to the absence of effective therapies as well as standard diagnostic procedures of early tumoral stages when compared with other cancers types, such as colon, breast and prostate cancers.

The study was funded by the National Institutes of Health and the Sbarro Health Research Organization.

Preston M. Moretz | Temple University
Further information:
http://www.nature.com/onc
http://jncicancerspectrum.oupjournals.org/jnci/content/vol90/issue19

More articles from Life Sciences:

nachricht Climate Impact Research in Hannover: Small Plants against Large Waves
17.08.2018 | Leibniz Universität Hannover

nachricht First transcription atlas of all wheat genes expands prospects for research and cultivation
17.08.2018 | Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>